IPO rumors are swirling around Sinopharm Medicine Holding Co., a major pharmaceutical distributor in China. According to the story, the IPO would take place on the Hong Kong stock exchange as early as October 2009. The goal would be to raise more than Hong Kong $2 billion ($155 million US). Sinopharm Medicine was founded in early 2003 by China National Pharmaceutical Group Corp. (Sinopharm) and Fosun Capital, with a total registered capital of 1 billion RMB. More details...